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During pregnancy, the maternal immune system faces a double dilemma: tolerate the
growing semi-allogeneic fetus and at the same time protect the mother and the prog-
eny against pathogens. This requires a fine and extremely regulated equilibrium between
immune activation and tolerance. As professional antigen presenting cells, B cells and in
particular B-1a B cells, can activate or tolerize T cells and thus participate in the gener-
ation or regulation of the immune response. B-1a B cells were involved in the humoral
immune response leading to pre-eclampsia, one of the main medical complications during
pregnancy. Here we demonstrated that B-1a B cells are additionally involved in cellular
immune mechanisms associated with pregnancy complications. Using a mouse model of
pregnancy disturbances, we showed that B-1a B cells from animals suffering pregnancy
disturbances but not from those developing normal pregnancies induce the differentiation
of naïveT cells intoTh17 andTh1 cells.This differential role of B-1a B cells during pregnancy
seems to be associated with the co-stimulatory molecule CD86 as normal pregnant mice
showed lower percentages of CD86 expressing B-1a B cells as compared to pregnant mice
developing pregnancy disturbances or to non-pregnant animals. Our data bring to light a
new and not explored role of B-1a B cells in the context of pregnancy.
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INTRODUCTION
Pregnancy in eutherian mammals represents a unique and fasci-
nating immunological process in which paternal, semi-allogeneic,
antigens carried by the fetus must to be “tolerated” by the mater-
nal immune system (1). This requires a fine and highly regulated
balance between immune activation, to ensure proper protec-
tion of the mother against pathogens, and immune tolerance that
allows the survival of the semi-allogeneic fetuses within the mater-
nal uterus. Minimal disturbances of this fine equilibrium may
have deleterious effect not only in the progeny but also in the
mother (1).
Paternal antigens, present in the semen, are being recognized
by the maternal immune system even before the process of fecun-
dation has taken place (2, 3). As pregnancy is established, embryo
starts growing and the transfer of fetal cells, as well as cell debris
into the maternal circulation increases (4). As for other antigens,
paternal antigens can be up-taken by maternal professional anti-
gen presenting cells (APCs), processed and presented to naïve
T cell encouraging their differentiation into different T cell lin-
eages, namely: Th1, Th2, Th17, or regulatory T cells depending on
different signals (2, 5–7).
Pregnancy wellbeing was classically associated with a shift
toward a Th2 profile while the prevalence of Th1 as well as Th17
cells is associated with different pregnancy-associated pathologies,
e.g., miscarriages (8, 9), intrauterine growth restriction (10),
pre-eclampsia (11, 12), and pre-term birth (13, 14).
Among professional APCs, peritoneal cavity (PerC) B-1a B cells
have been shown to be potent inducers of Th1 (15) as well as
Th17 T cell differentiation (16). However, under especial condi-
tions, e.g., CD86 blockage, B-1a B cells fail to induce Th1/17 T
cell polarization. Instead, they strongly boost the differentiation
of naïve T cells into newly expressing FOXP3 inducible regulatory
T cells (iTregs) (15).
We have previously demonstrated that B-1a B cells are involved
in the humoral immune response associated with the phys-
iopathology of pre-eclampsia, one of the leading causes of preg-
nancy complications (17). In this study we aimed to further
investigate the capacity of B-1a B cells to regulate the differen-
tiation of the pro-inflammatory Th17 and Th1 T cells subsets in a
murine model of pregnancy disturbances.
MATERIALS AND METHODS
ANIMALS AND ANIMAL MODEL OF PREGNANCY DISTURBANCES
Eight weeks old CBA/J (H2k) and C57BL/6 (H2b) females as
well as BALB/c (H2d) and DBA/2J (H2d) males were pur-
chased from Charles River (Germany/France). Mice were kept
in our animal facility under optimal conditions in a 12-h light
cycle. Chow and water were applied ad libitum. Animal experi-
ments were carried out according to institutional guidelines after
Ministerial approval [Reviewing board institution: Landesver-
waltungsamt Sachsen-Anhalt (ID: FJ2-101 to Federico Jensen)
and Landensamt für landwirtschaft Lebensmittelsicherheit und
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Fischrei Mecklenburg-Vorpommer (7221.3-1-068/13 to Federico
Jensen)]. The experiments were conducted in conformity with the
European Communities Council Directive.
A well-established model of pregnancy disturbances was used
(18). Briefly, when CBA/J females are mated to DBA/2J males,
a median of 20–30% of the embryos resorption (abortions) is
observed (19). Besides, pregnant females from this combination
are also characterized by angiogenic deregulation, abnormal pla-
cental development, and fetal growth restriction, all features of
pre-eclampsia (20). BALB/c mated CBA/J females represent the
normal pregnancy combination with a median of 0% of abortions
and none of the symptoms described above for the DBA/2J mated
CBA/J females.
Virgin females CBA/J mice were mated with BALB/c, or DBA/2J
males. Females were inspected daily for vaginal plugs, and presence
of a vaginal plug was designated as day 0 of pregnancy. Pregnant
females were sacrificed at day 14 of pregnancy.
ANTIBODIES AND REAGENTS
The following anti-mouse fluorescently labeled antibodies were
used: CD19 (clone 1D3), CD11b (clone M1/70), CD5 (clone
53-7.3), CD80 (clone 16-1OA1), MHCII (clone 2G9), CD86
(clone GL1) (BD Biosciences, Germany), and CD23 (clone
B3B4) (eBiosciences, Germany). Mitomycin-c was obtained from
Sigma-Aldrich, Germany. CD19 MicroBeads isolation kit, CD5
Microbeads isolation kit, and regulatory T cells isolation kit were
obtained from Miltenyi Biotec, Germany. Anti-mouse IL4 and
anti-mouse IFNγ were from BD, Biosciences, Germany. TGFβ
was purchased from R&D System, Germany. IL23 and IL6 were
obtained from eBiosciences, Germany. Cytometric bead array
(CBA) Mouse Th1/Th2/Th17 Cytokine Kit was obtained from BD,
Biosciences, Germany.
CELL ISOLATION AND CULTURE
CD19+CD5+ B-1a B cells were magnetically isolated from PerC
washouts of BALB/c or DBA/2J mated CBA/J pregnant females
on day 14 of pregnancy. As control B-1a B cells were isolated
from non-pregnant CBA/J females. Pure isolated B-1a B cells
were treated with mitomycin-c and used as APCs. CD4+CD25−
naïve T cells were isolated from lymph nodes of non-pregnant
C57BL/6 females. Isolated naïve T cells (2× 105) were cultured
with mitomycin-c inactivated B-1a B cells (1× 105) (2:1) in 96-
well round-bottom plates with 200µl of RPMI medium supple-
mented with SFB (10%) and antibiotics for 5 days with or without
the addition of a Th17 differentiation cytokines cocktail (10)
composed of anti IFNγ (10µg/ml), anti IL4 (10µg/ml), TGFβ
(3 ng/ml), IL6 (50 ng/ml), and IL23 (20 ng/ml). Supernatants were
collected and frozen at−80°C.
CELL STAINING AND FLOW CYTOMETRY
Peritoneal cavity cells were stained with specific antibodies or
matched isotype controls for 30 min at 4°C. After washing, cells
were analyzed with a FACSCalibur flow cytometer. Data were ana-
lyzed with FlowJo software (Tree Star Inc.). For analyzing the
expression levels of MCHII, CD80, CD86, PD-L1, PD-L2, and
FASL on CD19+CD23−CD5+ B-1a B cells mean fluorescence
index (MFI) was applied using FlowJo software (Tree Star Inc.).
CYTOKINE DETECTION IN SUPERNATANTS
Levels of IL17, TNFα, IFNγ, IL2, and IL6 cytokines were measured
in supernatants by CBA Mouse Th1/Th2/Th17 Cytokine Kit and
Th1/Th2 Inflammation Kit from BD Biosciences, following sup-
plier recommendation. MCP1 was measured by using an ELISA
kit from R&D System.
STATICS
The statistical significance of comparisons of median values was
assessed by the non-parametric Kruskal–Wallis test with GraphPad
software.
RESULTS
B-1a B CELLS FROM PREGNANT ANIMALS SUFFERING PREGNANCY
DISTURBANCES INDUCE Th17 T CELL DIFFERENTIATION WHILE B-1a B
CELLS FROM NORMAL PREGNANT MICE STRONGLY INHIBITED IT
Increasing evidence indicates that pregnancy disturbances, e.g.,
unexplained recurrent miscarriages (8) and pre-eclampsia (11)
are associated with a prevalence of Th17 cells. B-1a B cells are
potent inducers of Th17 cells differentiation (15, 16, 21, 22).
Taking these into account we aimed to explore here the differ-
ential capacity of B-1a B cells from pregnant mice developing
normal pregnancies or mice suffering from pregnancy distur-
bances to induce Th17 cell differentiation in vitro. Mitomycin-c
treated B-1a B cells were co-cultured with allogeneic CD4+CD25−
naïve T cells and the production of IL17 was assayed in super-
natants. In agreement with previous studies (16), B-1a B cells
isolated from non-pregnant virgin control mice induced a slight
production of IL17 by CD4+CD25− naïve T cells (Figure 1A).
This modest production of IL17 was lowered when T cells
were cultured with B-1a B cells isolated from normal preg-
nant mice, although differences did not reach statistical signif-
icance (Figure 1A). Interestingly, when B-1a B cells isolated
from animals suffering pregnancy disturbances were used to
stimulate T cells, a significantly higher production of IL17 was
observed as compared to T cells cultured with B-1a B cells
from normal pregnant mice (Figure 1A). No differences were
observed on IL17 production by T cells cultured with B-1a B
cells from non-pregnant mice compared to T cells cultured with
B-1a B cells from animal suffering from pregnancy disturbances
(Figure 1A).
Differentiation of Th17 cells can be induced in vitro by expos-
ing CD4+ T cells to optimal conditions of TGFβ, IL6, IL23, and
blocking IFNγ and IL4 (16). We next wondered whether B-1a
B cells from animals developing normal pregnancies not only
fail to induce IL17 production by T cells as compared to B-
1a B cells from animals suffering pregnancy disturbances but
also can inhibit Th17 differentiation even under optimal con-
ditions for Th17 development. We cultured CD4+CD25− naïve
T cells with B-1a B cells isolated from pregnant mice devel-
oping normal pregnancies with the addition of Th17 optimal
condition cytokines. In addition, T cells were cultured with B-
1a B cells from pregnant mice suffering pregnancy complica-
tions or from non-pregnant mice plus cytokines. As expected,
when CD4+CD25− naïve T cells were co-cultured with B-1a B
cells isolated either from non-pregnant mice or pregnant mice
developing pregnancy disturbances and cytokines were added,
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FIGURE 1 | B-1a B cells from normal pregnant animals but not from
pregnant animals suffering pregnancy disturbances inhibit Th17 T cell
differentiation. CD4+CD25− naïve T cells (2×105) were cultured with
mitomycin-c treated CD19+CD5+ B-1a B cells (1×105) (1:2) from
non-pregnant, BALB/c mated (normal pregnant) or DBA/2J mated
(developing pregnancy disturbances) CBA/J females without (A) or with
(B) the addition of a Th17 cytokine differentiation cocktail. Levels of IL17
were assayed in supernatants. Data are expressed as Box and Whisker
plots showing median. *P <0.05 as analyzed by the non-parametric
Kruskal–Wallis test.
a potent induction of IL17 production by naïve T cells was
observed (Figure 1B). Notably, the production of IL17 by T
cells in these two groups was ≈10-fold higher as compared to
the same groups without the addition of the Th17 stimulation
cocktail (Figure 1A). This clearly confirms the robustness of the
Th17 induction system. Remarkably, B-1a B cells isolated from
pregnant mice developing normal pregnancies strongly inhib-
ited the production of IL17 by CD4+CD25− naïve T cells even
under the addition of optimal cytokines conditions for Th17 cell
development (Figure 1B). These results clearly demonstrate a dif-
ferential capacity of B-1a B cells in the context of pregnancy:
while B-1a B cells from animals developing pregnancy distur-
bances induce Th17 cells polarization, B-1a B cells from animals
undergoing normal pregnancies manifested a strong inhibitory
capacity.
B-1a B CELLS FROM PREGNANT ANIMALS SUFFERING PREGNANCY
DISTURBANCES BUT NOT FROM THOSE DEVELOPING NORMAL
PREGNANCIES INDUCED THE PRODUCTION OF Th1 CYTOKINES BY T
CELLS
In addition to their capacity to induce Th17 differentiation, B-1a
B cells were also shown to participate in the induction of Th1
polarization (15). We next wondered whether in the context of
pregnancy, B-1a B cells might also have a differential role in induc-
ing/inhibiting Th1 polarization. We observed that mitomycin-c
treated B-1a B cells isolated from normal pregnant mice induced
a lower but not significant production of Th1 pro-inflammatory
cytokines, TNFα, IFNγ, IL2, and MCP1 by CD4+CD25− naïve
T cells as compared to B-1a B cells from non-pregnant control
animals (Figures 2A–D). However,when T cells were cultured with
B-1a B cells isolated from pregnant mice developing pregnancy
disturbances, significantly higher levels of Th1 pro-inflammatory
cytokines were observed as compared to T cells cultured with B-1a
B cells isolated from normal pregnant mice (Figures 2A–D). No
differences were observed on Th1 cytokines production by T cells
cultured with B-1a B cells from non-pregnant mice compared to
T cells cultured with B-1a B cells from animal suffering from preg-
nancy disturbances (Figures 2A–D). These results demonstrate
that B-1a B cells from pregnant mice developing normal pregnan-
cies induced a significantly lower production of Th1 cytokines by T
cells as compared to B-1a B cells from animals suffering pregnancy
disturbances.
LEVELS OF B-1a B CELLS IN PerC DO NOT CHANGE DURING
PREGNANCY
We next concentrated in the mechanisms behind the differential
capacity of B-1a B cells from pregnant animals having normal
pregnancies and those developing pregnancies disturbances in
the regulation of Th1/17 T cell differentiation. We began ana-
lyzing the percentages of CD19+CD23−CD11b+CD5+ B-1a B
cells (23) in the PerC of pregnant and non-pregnant mice. As
displayed in Figure 3 no differences were observed concerning
the percentages of CD19+CD23−CD11b+CD5+ B-1a B cells in
the PerC of pregnant animals having normal pregnancies com-
pared to those suffering pregnancy disturbances and to non-
pregnant controls. We have additionally analyzed the percentages
of CD19+CD23−CD11b+CD5− B-1b cells as well as CD19+C23+
B2 B cells. Neither the percentages of B-1b cells (Figure A1A
in Appendix) nor percentages of B2 B cells (data not showed)
in PerC of non-pregnant as well as normal pregnant mice or
animals suffering pregnancy disturbances were modified. These
results suggest that the differential capacity of B-1a B cells from
normal pregnant mice in inhibiting Th17/1 T cell differentia-
tion compared to B-1a B cells from animal suffering pregnancy
disturbances, is not related to changes in the levels of B-1a B cells.
PREGNANT ANIMALS DEVELOPING NORMAL PREGNANCIES AND
ANIMALS SUFFERING PREGNANCY DISTURBANCES HAVE SIMILAR
LEVELS OF MHCII EXPRESSING B-1a B CELLS
B cells present antigens to T cells in the context of MHCII mole-
cule (24, 25). Having observed that percentages of B-1a B cells do
not differ between animals having normal pregnancies compared
to those developing pregnancy disturbances or to non-pregnant
mice, we next analyzed the expression levels of MHCII molecule
on CD19+CD23−CD5+ B-1a B cells as well as the percentages
of MHCII expressing CD19+CD23−CD5+ B-1a B cells in non-
pregnant as well as pregnant mice having normal pregnancies
or developing pregnancies disturbances. Neither the expression
levels of MHCII in CD19+CD23−CD5+ B-1a B (MFI: 2.7, 2.8,
and 2.4, respectively) nor the percentages of MHCII express-
ing CD19+CD23−CD5+ B-1a B cells in PerC were modified
among the groups (Figure 4). Similar results were observed when
analyzing MHCII expression on CD19+CD23−CD5− B-1b cells
(Figure A1B in Appendix)
www.frontiersin.org January 2014 | Volume 5 | Article 6 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Muzzio et al. B-1a B cells in pregnancy
FIGURE 2 | B-1a B cells from pregnant animals developing
pregnancy complications but not from those having normal
pregnancies induce Th1 T cell polarization. CD4+CD25− naïve T cells
(2×105) were cultured with CD19+CD5+ B-1a B cells (1×105) (2:1)
from non-pregnant, BALB/c (normal pregnant) or DBA/2J (developing
pregnancy disturbances) pregnant CBA/J females. Levels of TNFα
(A), IFNγ (B), IL2 (C), and MCP1 (D)Th1 cytokines were analyzed in
supernatants. Data are expressed as Box and Whisker plots showing
median. *P <0.05 as analyzed by the non-parametric Kruskal–Wallis
test.
PERCENTAGES OF CD86 EXPRESSING B-1a B CELLS ARE DIMINISHED
DURING NORMAL PREGNANCY
Activation and differentiation of naïve T cells upon antigen pre-
sentation require a proper interaction of CD28 expressed on T
cells with co-stimulatory molecules (CD86 and CD80) expressed
on APC (26–28). We observed similar levels of CD80 and CD86
expression on PerC CD19+CD23−CD5+ B-1a B cells from non-
pregnant mice compared to pregnant mice developing normal,
pregnancies or suffering pregnancy disturbances (CD80 MFI: 2.2,
2.2, and 2.5; CD86 MFI: 2.3, 2.1, and 2.4, respectively). How-
ever, percentages of CD86 expressing CD19+CD23−CD5+ B-1a
B cells were significantly lower in PerC of pregnant mice devel-
oping normal pregnancies as compared to those suffering preg-
nancy disturbances or to non-pregnant control mice (Figure 5A).
No differences were observed concerning percentages of CD80
expressing CD19+CD23−CD5+ B-1a B cells among the groups
(Figure 5B). We have also analyzed the percentages of CD86 and
CD80 expressing CD19+CD23−CD5− B-1b cells in PerC of non-
pregnant as well as normal pregnant or pregnant mice suffering
pregnancy disturbances and did not find any difference among the
groups (Figure A1B in Appendix).
We have additionally studied the expression levels of cellular
markers (PD-L1, PD-L2, and FASL) on CD19+CD23−CD5+ B-
1a B cells, all well known to take part in the interaction between
B-1a and T cells. As for other cellular markers analyzed in this study
we did not find any difference in the expression levels of PD-L1
(MFI: 318.5; 327 and 310, respectively), PD-L2 (MFI: 145, 138,
and 141, respectively), and FASL (MFI: 36.70, 30.80, and 30.40,
respectively) as well as in the percentages of PD-L1 (100% of B-1a
B cells of all groups expressed PD-L1, data not showed), PD-L2
and FASL expressing CD19+CD23−CD5+ B-1a B cells between
the groups (Figure A2 in Appendix). These results suggest that
the lower percentages of CD86 expressing B-1a B cells observed
in normal pregnant animals may be one of the mechanisms as
how these cells fails to induce Th1 and strongly inhibit Th17 T cell
differentiation during normal pregnancy.
DISCUSSION
The ability of B-1 B cells to induce the polarization of naïve T
cells into pro-inflammatory Th17 and Th1 T cell subsets has been
extensively demonstrated (15, 16, 21, 22). In this study we have
confirmed and extended these results by showing that in the con-
text of pregnancy B-1a B cells display a differential capacity in
term of regulating pro-inflammatory T cell differentiation. B-1a B
cells from pregnant mice developing normal pregnancies not only
failed to induce Th17 differentiation but also showed to have a
strong inhibitory capacity even in a favorable environment for the
differentiation of Th17 cells. Notably, this inhibitory effect was not
achieved when B-1a B cells were isolated from pregnant animals
suffering pregnancy disturbances, clearly demonstrating a differ-
ential capacity of B-1a B cells from normal pregnant animals in
controlling Th17 T cell differentiation.
Similarly, B-1a B cells from pregnant animals suffering preg-
nancy disturbances but not from animals developing normal
pregnancies induced the production of pro-inflammatory Th1
cytokines by naïve T cells. These results suggest that during nor-
mal pregnancy B-1a B cells are turned into an transient state of
tolerance that unable them to induce pro-inflammatory T cell acti-
vation and differentiation that can be deleterious for pregnancy to
be maintained (29).
Activation of naïve T cells and posterior maturation into dif-
ferent T cell lineages is a multistep phenomenon requiring both,
antigen-specific triggering of the T cell receptor complex and
additional signaling via co-stimulatory molecules (26, 27). B cell
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FIGURE 3 | Percentages of B-1a B cells do not change during pregnancy.
(A) Representative counter plots displaying the gating strategy used to
analyze the percentages of CD19+CD23−CD11b+CD5+ B-1a B cells in the
PerC of non-pregnant and pregnant mice. (B) Graph displays percentages of
CD19+CD23−CD11b+CD5+ B-1a B cells in the PerC of non-pregnant as well as
BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances) pregnant
CBA/J females. Data are expressed as Box and Whisker plots showing
median. Differences were analyzed by the non-parametric Kruskal–Wallis test.
antigen presentation to T cells occurs in the context of MHCII
molecule and the interaction of CD28 receptor expressed on T
cells with CD86 and CD80 ligands expressed on the B cells (24,
28). Blockage of CD28 and their ligands, CD86 (30) and CD80, has
been shown to induce antigen-specific peripheral tolerance (15).
In this regards, we showed a significant reduction in the percent-
ages of CD86 expressing B-1a B cells in PerC of animals developing
normal pregnancies as compared to non-pregnant mice and to
pregnant mice suffering pregnancy disturbances. To note is the
fact that despite the observed differences in the percentages of
CD86 expressing B-1a B cells, the expression levels of CD86 in
B-1a B cells, analyzed by MFI, was similar between the groups.
Based on our results it is tempting to speculate that the reduc-
tion in the percentages of CD86 expressing B-1a B cells rather
than down-regulation of CD86 itself on B-1a B cells, represents
an adaptive mechanisms aimed to avoid undesired activation of
pro-inflammatory T cells that can have a deleterious effect on
pregnancy outcome. Interestingly, using the same animal model
of pregnancy disturbance we used in this study, Jin and co-authors
have showed that blocking CD86 with specific antibody, consid-
erably improved pregnancy outcome in pregnant mice otherwise
undergoing pregnancy disturbances (30, 31). In addition, Wang
and Rothstein using either a CD86 neutralizing antibody or B-1a
B cells isolated from CD86 KO animals have recently showed that
the lack of CD86 expression on B-1a B cells is linked to their inca-
pacity to induce Th17 differentiation (16). In keeping with our
results, Zhong and co-authors have nicely demonstrated that the
ability of B-1a B cells to stimulate alloreactive T cells can be inhib-
ited by blocking CD86 expression on B-1a B cells, rather under this
condition, B-1a B cells favor the development of inducible FOXP3
newly expressing regulatory T cells (iTregs) (15).
In conclusion, we have demonstrated in this study that B-1a
B cells manifest a differential capability in terms of regulating
pro-inflammatory T cell activation and differentiation during
pregnancy. Besides, we provided evidences that this differential
capacity may be associated with the levels of CD86 expressing
B-1a B cells.
Overall, we provided evidences highlighting the central role of
B-1a B cells in controlling pro-inflammatory T cell activation and
polarization in the context of pregnancy. This opens a new avenue
for exploring strategies to control undesired immune activation
that may compromise pregnancy outcome.
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FIGURE 4 | B-1a B cells from pregnant animals developing normal
pregnancies and animals suffering pregnancy disturbances display
similar levels of MHCII expressing B-1a B cells. (A) Representative contour
and density plots displaying the gating strategy used to analyze the
percentages of MHCII expressing CD19+CD23−CD5+ B-1a B cells in the PerC
of non-pregnant and pregnant mice. (B) Graph depicts percentages of MHCII
expressing CD19+CD23−CD5+ PerC B-1a B cells from non-pregnant as well
as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances) pregnant
CBA/J females. Data are expressed as Box and Whisker plots showing
median. Differences were analyzed by the non-parametric Kruskal–Wallis test.
FIGURE 5 | CD86 expressing B-1a B cells are diminished in pregnant
mice developing normal pregnancies but not in those suffering
pregnancy disturbances. (A) Representative contour and density plots
depicting gating strategy used to quantify percentages of CD86
expressing CD19+CD23−CD5+ PerC B-1a B cells of non-pregnant as well
as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances)
pregnant CBA/J females. Graph shows percentages of CD86 expressing
CD19+CD23−CD5+ PerC B-1a B cells. (B) Representative contour and
density plots depicting gating strategy used to quantify the percentages of
CD80 expressing CD19+CD23−CD5+ PerC B-1a B cells of non-pregnant as
well as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances)
pregnant CBA/J females. Graph shows percentages of CD80 expressing
CD19+CD23−CD5+ PerC B-1a B cells from non-pregnant as well as BALB/c
or DBA/2J mated CBA/J females. Data are expressed as Box and Whisker
plots showing median. *P < 0.05 as analyzed by the non-parametric
Kruskal–Wallis test.
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FIGUREA1 | Percentages of B-1b cells as well as percentages of MHCII,
CD86, and CD80 expressing B-1b cells are similar in normal pregnant
mice and in pregnant mice suffering pregnancy disturbances. (A) Graph
showing no differences in PerC CD19+CD23−CD11b+CD5− B-1b cells
percentages between non-pregnant and normal pregnant mice or pregnant
mice suffering pregnancy disturbances. (B) Percentages of MHCII, CD80, and
CD86 expressing PerC CD19+CD23−CD5− B-1b cells are similar among the
groups.
FIGUREA2 | Levels of FASL and PD-L2 expressing B-1a B cells are not affected in normal as well as disturbed pregnancies. Levels of FASL (A) and
PD-L2 (B) expressing CD19+CD23−CD5+ PerC B-1a B cells are similar between non-pregnant and pregnant mice.
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